STELLA PHARMA CORPORATION announced today that our Company has entered into a D……
Our product Borofalan (10B) (development code: SPM-011), which we are developin……
Stella Pharma completed the enrollment of patients for the domestic phase II do……
Stella Pharma announces that it has signed an agreement with the National Cance……
The Paper “Overcoming immunotherapy resistance and inducing abscopal effects wi……
― Providing our drug for Research on FDG-PET-positive shallow tumors ― Stell……
The paper “Efficacy and safety of boron neutron capture therapy for Hypopharyng……
We would like to announce that our company submitted the trial plan notificatio……
A paper containing the treatment results of unresectable, locally recurrent or ……
Together with China Biotech Services Holdings Limited (CBSH), our partner for t……
Our company provides Steboronine® for the investigator-initiated specified clin……
The international science journal “Nature” published in its special edition “Ra……
